Dexamethasone Down-regulates Osteocalcin in Bone Cells through Leptin Pathway.

about

Dexamethasone Down-regulates Osteocalcin in Bone Cells through Leptin Pathway.

Item

http://www.wikidata.org/entity/Q52725363

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Dexamethasone Down-regulates Osteocalcin in Bone Cells through Leptin Pathway.

@en

Dexamethasone Down-regulates Osteocalcin in Bone Cells through Leptin Pathway.

@nl

type

Item

label

Dexamethasone Down-regulates Osteocalcin in Bone Cells through Leptin Pathway.

@en

Dexamethasone Down-regulates Osteocalcin in Bone Cells through Leptin Pathway.

@nl

prefLabel

Dexamethasone Down-regulates Osteocalcin in Bone Cells through Leptin Pathway.

@en

Dexamethasone Down-regulates Osteocalcin in Bone Cells through Leptin Pathway.

@nl

P1476

Dexamethasone Down-regulates Osteocalcin in Bone Cells through Leptin Pathway.

@en

P2093

Chih-Chien Wang

http://www.w3.org/2001/XMLSchema#string

Donald M Salter

http://www.w3.org/2001/XMLSchema#string

Herng-Sheng Lee

http://www.w3.org/2001/XMLSchema#string

Shu-Mei Chen

http://www.w3.org/2001/XMLSchema#string

Sui-Lung Su

http://www.w3.org/2001/XMLSchema#string

Yi-Jen Peng

http://www.w3.org/2001/XMLSchema#string

P2860

BMI and BMD: The Potential Interplay between Obesity and Bone Fragility

Influence of body weight on bone mass, architecture and turnover

Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism

The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis

Leptin regulation of bone resorption by the sympathetic nervous system and CART

Cell biology of fat storage

A talk between fat tissue, gut, pancreas and brain to control body weight.

Local leptin production in osteoarthritis subchondral osteoblasts may be responsible for their abnormal phenotypic expression.

Leptin receptor (Lepr) is a negative modulator of bone mechanosensitivity and genetic variations in Lepr may contribute to the differential osteogenic response to mechanical stimulation in the C57BL/6J and C3H/HeJ pair of mouse strains.

Significance of increased leptin expression in osteoarthritis patients

P304

507-516

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/IJMS.21881

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29559840

http://www.w3.org/2001/XMLSchema#string

P921

dexamethasone

P932

5859774

http://www.w3.org/2001/XMLSchema#string